Home › Research › Topics › amyloid-protein
amyloid-protein
6 studies tagged amyloid-protein, dated 2000-12-01 to 2020-03-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Platelet Amyloid-β Protein Precursor (AβPP) Ratio and Phosphorylated Tau as Promising Indicators for Early Alzheimer's Disease 2020-03-01
- Blood amyloid-β protein isoforms are affected by HIV-1 in a subtype-dependent pattern 2019-07-07
- Changes of the enteric nervous system in amyloid-β protein precursor transgenic mice correlate with disease progression 2013-01-01
Studies
6 studies carry this tag.
Date range
2000 to 2020
Top journals
- Journal of Alzheimer's disease : JAD 2
- Experimental neurology 1
- Journal of neurovirology 1
- The American journal of pathology 1
- The journals of gerontology. Series A, Biological sciences and medical sciences 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
To identify whether platelet amyloid-β protein precursor (AβPP) ratio, phosphorylated-tau (P-tau) 231, P-tau181, and serine 396 and 404 (Ser396/404) phosphorylated tau are potential peripheral indicators for early Alzheimer's disease (AD).
-
This study aimed to compare serum amyloid processing biomarkers among HIV subtype B (n = 25), HIV subtype C (n = 26), healthy HIV-negative controls (n = 18), and patients with Alzheimer's disease (AD; n = 24).
-
In Alzheimer's disease (AD), fatal neuronal cell loss occurs long before relevant evidence can lead to a reliable diagnosis.
-
Despite growing evidence indicating the effects of cytokines, including interleukin-1beta (IL-1β) and tumour necrosis factor-α (TNFα), and the enzyme cyclooxygenase-2 (COX-2) in Alzheimer's diseases, little is known about the signalling mechanisms that mediate its activation in response to beta-amyloid protein (Aβ).
-
36/100
Mounting evidence suggests that Alzheimer's disease (AD) is caused by the accumulation of the small peptide, amyloid-β (Aβ), a proteolytic cleavage product of amyloid-β protein precursor (AβPP).
-
Proteases and their inhibitors play key roles in physiological and pathological processes.